[Congressional Record (Bound Edition), Volume 150 (2004), Part 6]
[House]
[Pages 7610-7611]
[From the U.S. Government Publishing Office, www.gpo.gov]




                     EXECUTIVE COMMUNICATIONS, ETC.

  Under clause 8 of rule XII, executive communications were taken from 
the Speaker's table and referred as follows:


[[Page 7611]]

       7839. A letter from the Alternate OSD Federal Register 
     Liaison Officer, Department of Defense, transmitting the 
     Department's final rule -- Civilian Health and Medical 
     Program of the Uniformed Services (CHAMPUS)/TRICARE; 
     Implementation of the Pharmacy Benefits Program (RIN: 0720-
     AA63) received April 6, 2004, pursuant to 5 U.S.C. 
     801(a)(1)(A); to the Committee on Armed Services.
       7840. A letter from the Alternate OSD Federal Register 
     Liaison Officer, Department of Defense, transmitting the 
     Department's final rule -- TRICARE; Civilian Health and 
     Medical Program of the Uniformed Services (CHAMPUS); Special 
     Supplemental Food Program for Women, Infants, and Children 
     Overseas (RIN: 0720-AA75) received March 31, 2004, pursuant 
     to 5 U.S.C. 801(a)(1)(A); to the Committee on Armed Services.
       7841. A letter from the Alternate OSD Federal Register 
     Liaison Officer, Department of Defense, transmitting the 
     Department's final rule -- Civilian Health and Medical 
     Program of the Uniformed Services (CHAMPUS)/TRICARE; 
     Implementation of the Pharmacy Benefits Program (RIN: 0720-
     AA63) received March 26, 2004, pursuant to 5 U.S.C. 
     801(a)(1)(A); to the Committee on Armed Services.
       7842. A letter from the Acting Assistant Secretary for 
     Communications and Information, Department of Commerce, 
     transmitting the Department's final rule -- Technology 
     Opportunities Program [Docket No. 981203295-4044-09] received 
     April 9, 2004, pursuant to 5 U.S.C. 801(a)(1)(A); to the 
     Committee on Energy and Commerce.
       7843. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Humam 
     Services, transmitting the Department's final rule -- Prior 
     Notice of Imported Food Under the Public Health Security and 
     Bioterrorism Preparedness and Response Act of 2002 [Docket 
     No. 02N-0278] (RIN: 0910-AC41) received April 7, 2004, 
     pursuant to 5 U.S.C. 801(a)(1)(A); to the Committee on Energy 
     and Commerce.
       7844. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- Removal 
     of Delegations of Authority and Conforming Changes to 
     Regulations [Docket No. 2004N-0142] received April 14, 2004, 
     pursuant to 5 U.S.C. 801(a)(1)(A); to the Committee on Energy 
     and Commerce.
       7845. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- 
     Prescription Drug Marketing Act of 1987; Prescription Drug 
     Amendments of 1992; Policies, Requirements, and 
     Administrative Procedures; Delay of Effective Date [Docket 
     No. 1992N-0297] (RIN: 0905-AC81) received April 6, 2004, 
     pursuant to 5 U.S.C. 801(a)(1)(A); to the Committee on Energy 
     and Commerce.
       7846. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- 
     Prescription Drug Marketing Act of 1987; Prescription Drug 
     Aemdments of 1992; Policies, Requirements, and Administrative 
     Proceduers; Delay of Effective Date; Correction [Docket No. 
     1992N-0297] (RIN: 0905-AC81) received April 6, 2004, pursuant 
     to 5 U.S.C. 801(a)(1)(A); to the Committee on Energy and 
     Commerce.
       7847. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- 
     Biological Products; Bacterial Vaccines and Toxoids; 
     Implementation of Efficacy Review; Correction [Docket No. 
     1980N-0208] received April 6, 2004, pursuant to 5 U.S.C. 
     801(a)(1)(A); to the Committee on Energy and Commerce.
       7848. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- Drug 
     Labeling; Orally Ingested Over-the-Counter Drug Products 
     Containing Calcium, Magnesium, and Potassium [Docket No. 
     1995N-0254] received April 7, 2004, pursuant to 5 U.S.C. 
     801(a)(1)(A); to the Committee on Energy and Commerce.
       7849. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- Drug 
     Labeling; Sodium Labeling for Over-the-Counter Drugs; 
     Technical Amendment; Termination of Delay of Effective Date; 
     Compliance Dates [Docket No. 900N-0309] received April 7, 
     2004, pursuant to 5 U.S.C. 801(a)(1)(A); to the Committee on 
     Energy and Commerce.
       7850. A letter from the Director, Regulations Policy and 
     Management Sta., FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- Change 
     of Address; Technical Amendment -- received April 6, 2004, 
     pursuant to 5 U.S.C. 801(a)(1)(A); to the Committee on Energy 
     and Commerce.
       7851. A letter from the Deputy Assistant Secretary for 
     Labor-Management Programs, Department of Labor, transmitting 
     the Department's final rule -- Obligations of Federal 
     Contractors and Subcontractors; Notice of Employee Rights 
     Concerning Payment of Union Dues or Fees (RIN: 1215-AB33) 
     received April 1, 2004, pursuant to 5 U.S.C. 801(a)(1)(A); to 
     the Committee on Government Reform.
       7852. A letter from the Deputy Associate Administrator, 
     Office of Acquisition Policy, GSA, National Aeronautics and 
     Space Administration, transmitting the Administration's final 
     rule -- Federal Acquisition Regulation; Special Emergency 
     Procurement [FAC 2001-20; FAR Case 2003-022] (RIN: 9000-AJ88) 
     received March 25, 2004, pursuant to 5 U.S.C. 801(a)(1)(A); 
     to the Committee on Government Reform.
       7853. A letter from the Deputy Associate Administrator, 
     Office of Acquisition Policy, GSA, National Aeronautics and 
     Space Administration, transmitting the Administration's final 
     rule -- Federal Acquisition Regulation; Purchases from 
     Federal Prison Industries -- Requirement for Market Research 
     [FAC 2001-21; FAR Case 2003-023] (RIN: 9000-AJ91) received 
     April 15, 2004, pursuant to 5 U.S.C. 801(a)(1)(A); to the 
     Committee on Government Reform.
       7854. A letter from the Deputy Associate Administrator, 
     Office of Acquisition Policy, GSA, National Aeronautics and 
     Space Administration, transmitting the Administration's final 
     rule -- Federal Acquisition Circular 2001-22; Introduction -- 
     received April 15, 2004, pursuant to 5 U.S.C. 801(a)(1)(A); 
     to the Committee on Government Reform.
       7855. A letter from the Deputy Archivist, National Archives 
     and Records Administration, transmitting the Administration's 
     final rule -- Publication of Revised Bylaws of the 
     Interagency Security Classification Appeals Panel [Directive 
     No. 1: Appendix A] Recieved April 2, 2004, pursuant to 5 
     U.S.C. 801(a)(1)(A); to the Committee on Government Reform.
       7856. A letter from the Secretary, Administrative Committee 
     of the Federal Register, National Archives and Records 
     Administration, transmitting the Administration's final rule 
     -- Price Changes to Federal Register Publications (RIN: 3095-
     AB35) received April 9, 2004, pursuant to 5 U.S.C. 
     801(a)(1)(A); to the Committee on Government Reform.
       7857. A letter from the Regulations Coordinator, Centers 
     for Medicare and Medicaid Services, Department of Health and 
     Human Service, transmitting the Department's final rule -- 
     Medicare Program; Manufacturer Submission of Manufacturer's 
     Average Sales Price (ASP) Data for Medicare Part B Drugs and 
     Biologicals [CMS-1380-IFC] (RIN: 0938-AN05) received April 6, 
     2004, pursuant to 5 U.S.C. 801(a)(1)(A); jointly to the 
     Committees on Energy and Commerce and Ways and Means.

                          ____________________